Invokamet and Losartan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Invokamet (canagliflozin; metformin hydrochloride) and Losartan (losartan potassium). Common drug interactions include blood potassium decreased among females and glycosylated haemoglobin increased among males.

The phase IV clinical study analyzes what interactions people have when they take Invokamet and Losartan. It is created by eHealthMe based on reports of 74 people who take the same drugs from the FDA, and is updated regularly.

What is Invokamet?

Invokamet has active ingredients of canagliflozin; metformin hydrochloride. eHealthMe is studying from 1,965 Invokamet users. Check the latest studies of Invokamet.

What is Losartan?

Losartan has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 177,692 Losartan users. Check the latest studies of Losartan.



On Aug, 12, 2026

74 people who take Invokamet and Losartan together, and have interactions are studied.

Invokamet and Losartan drug interactions.

What are the common drug interactions of Invokamet and Losartan, by gender? *:

female:

  1. Blood potassium decreased
  2. Blood potassium increased
  3. Blood urine present
  4. Cardiac arrest
  5. Cellulitis (infection under the skin)
  6. Chest discomfort
  7. Cold sweat
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Cough
  10. Creatinine renal clearance increased

male:

  1. Glycosylated haemoglobin increased
  2. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  3. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  4. Adverse event
  5. Affect lability (emotional incontinence)
  6. Agitation (state of anxiety or nervous excitement)
  7. Neck pain
  8. Palpitations (feelings or sensations that your heart is pounding or racing)
  9. Road traffic accident
  10. Skin disorder (skin disease)

What are the common drug interactions of Invokamet and Losartan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Blood calcium increased
  2. Glycosylated haemoglobin increased

40-49:

  1. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  2. Adverse event
  3. Affect lability (emotional incontinence)
  4. Agitation (state of anxiety or nervous excitement)
  5. Bacterial prostatitis (bacterial infection of the prostate gland)
  6. Fungal infection
  7. Papillary thyroid cancer
  8. Urinary tract infection

50-59:

  1. Chronic kidney disease
  2. Cough
  3. Creatinine renal clearance increased
  4. Diarrhoea
  5. Dyspareunia (painful sexual intercourse)
  6. Glycosylated haemoglobin increased
  7. Haematuria (presence of blood in urine)
  8. Hyperhidrosis (abnormally increased sweating)
  9. Hyperkalaemia (damage to or disease of the kidney)
  10. Hypermagnesaemia (an electrolyte disturbance in which there is an abnormally elevated level of magnesium in the blood)

60+:

  1. Fall
  2. Injection site nodule (small swelling or aggregation of cells in the body, esp. an abnormal one at injection site)
  3. Pulmonary congestion (congestion in the lungs)
  4. Abasia (inability to walk)
  5. Abdominal discomfort
  6. Abdominal pain
  7. Alopecia (absence of hair from areas of the body)
  8. Asthma
  9. Blood creatinine increased
  10. Blood potassium decreased

What are the existing conditions these people have? *

  1. Diabetes: 21 people, 28.38%
  2. Type 2 Diabetes: 20 people, 27.03%
  3. High Blood Cholesterol: 13 people, 17.57%
  4. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 12 people, 16.22%
  5. Cushing's Syndrome (obesity, a rounded face, increased fat): 11 people, 14.86%
  6. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 8 people, 10.81%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 9.46%
  8. Pain: 6 people, 8.11%
  9. Rickets (softening of bones): 5 people, 6.76%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Invokamet and Losartan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Invokamet and Losartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Invokamet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Losartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Invokamet and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Losartan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on canagliflozin; metformin hydrochloride and losartan potassium (the active ingredients of Invokamet and Losartan, respectively), and Invokamet and Losartan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: